chr2-58139755-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000340157.9(VRK2):c.946C>T(p.His316Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,613,144 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000340157.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VRK2 | NM_006296.7 | c.946C>T | p.His316Tyr | missense_variant | 11/13 | ENST00000340157.9 | NP_006287.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VRK2 | ENST00000340157.9 | c.946C>T | p.His316Tyr | missense_variant | 11/13 | 1 | NM_006296.7 | ENSP00000342381 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000671 AC: 102AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251164Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135756
GnomAD4 exome AF: 0.0000801 AC: 117AN: 1461054Hom.: 2 Cov.: 30 AF XY: 0.0000743 AC XY: 54AN XY: 726844
GnomAD4 genome AF: 0.000671 AC: 102AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.000713 AC XY: 53AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.946C>T (p.H316Y) alteration is located in exon 11 (coding exon 10) of the VRK2 gene. This alteration results from a C to T substitution at nucleotide position 946, causing the histidine (H) at amino acid position 316 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at